Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin

Combining chemotherapy and targeted therapies has resulted in an enhanced survival in metastatic colorectal cancer (mCRC) patients. However, the result of this palliative treatment in patients with metachronous peritoneal carcinomatosis (PC) remains unknown. The current population-based study aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: van Oudheusden, T. R., Razenberg, L. G., van Gestel, Y. R., Creemers, G. J., Lemmens, V. E., de Hingh, I. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685443/
https://www.ncbi.nlm.nih.gov/pubmed/26686250
http://dx.doi.org/10.1038/srep18632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685443/
https://www.ncbi.nlm.nih.gov/pubmed/26686250
http://dx.doi.org/10.1038/srep18632

Ejemplares similares